MATAURO’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

MATAURO’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Buy	7,447 +30	+0.4%	+$900	0.03%	133
2026 Q1	$215K	Buy	+7,417	New	+$215K	0.03%	130
2025 Q4	–	Sell	-11,067	Closed	-$261K	–	163
2025 Q3	$261K	Buy	11,067 +1,097	+11%	+$24.3K	0.04%	124
2025 Q2	$204K	Buy	9,970 +73	+0.7%	+$1.47K	0.04%	129
2025 Q1	$203K	Hold	9,897	–	–	0.04%	116
2024 Q4	$224K	Buy	+9,897	New	+$238K	0.05%	105

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MATAURO's IDNA Position: Q2 2026 in Review

MATAURO increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 0.4% in Q2 2026, buying an estimated $900 and bringing the position to 7,447 shares worth $251K. The position accounts for 0.03% of the portfolio, ranked #133.

MATAURO first reported a position in IDNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $261K in Q3 2025. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

MATAURO held 7,447 shares of iShares Genomics Immunology and Healthcare ETF worth $251K as of Q2 2026.
MATAURO bought 30 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $900.
iShares Genomics Immunology and Healthcare ETF made up 0.03% of MATAURO's portfolio in Q2 2026, its #133 holding.
MATAURO first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2024 and has held it in 6 quarters since.
MATAURO's iShares Genomics Immunology and Healthcare ETF position peaked at $261K in Q3 2025.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on MATAURO's 13F filing for Q2 2026, filed 21 Jul 2026.